Intrinsic value of Teva Pharmaceutical Industries Limited (TEVA)
Live fair value data for Teva Pharmaceutical Industries Limited (TEVA) is currently unavailable. Please check again shortly.
Current Price: $284.00
Valuation: Undervalued
Confidence: 4.0/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Teva Pharmaceutical Industries Limited (TEVA) undervalued or overvalued?
Based on the current model output, Teva Pharmaceutical Industries Limited appears to be undervalued with a upside of 2.00%.
Fair value vs market price — Teva Pharmaceutical Industries Limited (TEVA)
Unlock premium access to view the live fair value comparison against current market price for TEVA.
Frequently Asked Questions - TEVA
How is TEVA intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for TEVA.
Is TEVA undervalued or overvalued right now?
TEVA is currently shown as undervalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for TEVA: open their intrinsic value pages.